说明:双击或选中下面任意单词,将显示该词的音标、读音、翻译等;选中中文或多个词,将显示翻译。
您的位置:首页 -> 句库 -> 华法林
1.
Clinical Study of Warfarin in Treating Atrial Fibrillation in the Old Patients;
老年房颤患者应用华法林的临床研究
2.
Introduction of Clinical Therapy and Bleeding Complication of Warfarin
华法林临床应用及出血不良反应介绍
3.
Corpus luteum rupture induced by warfarin overdose:one case report
华法林过量致卵巢黄体破裂1例分析
4.
Diet Nursing of Warfarin Anticoagulation Treatment in Atrial Fibrillation Patients
房颤患者华法林抗凝治疗的饮食调护
5.
Anticoagulant therapy of Warfarin in patients with no-valvular heart disease and atrial fibrillation
非瓣膜病房颤的华法林抗凝治疗研究
6.
The Synthesis of Coumarin Anticoagulants Warfarin and It's Analogs;
香豆素类抗凝血药华法林及其类似物的合成
7.
The Influence of PXR and OATP1B1 Gene Polymorphism on Therapeutic Dose of Warfarin
核受体PXR和OATP1B1基因多态性对华法林剂量的影响
8.
In Vitro Metabolism and Drug Interactions of Warfarin
华法林的体外代谢及药物相互作用研究
9.
Clinical observation of Warfarin in the treatment of 27 cases of lower limb deep venous thrombosis
华法林治疗下肢深静脉血栓27例疗效观察
10.
Clinical Analysis on Hematuria Caused by Oral Warfarin among Elderly Patients
老年患者服用华法林导致血尿的临床分析
11.
Clinical Study of Warfarin Anticoagulation Therapy in Patients after Mechanical Heart Valve Replacement
心脏机械瓣膜置换术后华法林抗凝治疗的研究
12.
Therapeutic Monitoring Anticoagulation of Warfarin in Patients with Prosthetic Heart Valve Replacement;
人工机械心脏瓣膜置换术后华法林抗凝治疗的监测
13.
Study on CYP2C9 Polymorphism and Warfarin Dosage Requirement in Population of Han Nationality in China;
中国汉族人CYP2C9遗传多态性与华法林剂量调整的研究
14.
The Efficiency and Safety of Anticoagulation Therapy by Combination of Herbs with Effects of Activating Blood Circulation and Dispersing Stasis and Warfarin Sodium in Chronic Atrial Fibrillation in Chinese;
活血化瘀药联合华法林对慢性房颤抗凝疗效及安全性观察
15.
The Effect of CYP2C9 SNP on the Warfarin s Stable Doses of 30 Chinese Mongolian Heart Disease Patients;
CYP2C9基因的多态性对30名汉族心脏病患者华法林稳定维持量的影响
16.
The Effect of Danshen on Steady State Warfarin Pharmacodynamics and Pharmacokinetics in Rats;
丹参注射液对大鼠体内稳态华法林药动学和药效学参数的影响
17.
Gene Polymorphism of CYP450 2C9 and VKORC1 and Their Relationship with Warfarin Maintaining Dose;
CYP4502C9和VKORC1的基因多态性及其他因素与华法林剂量的相关性研究
18.
The Effects of Soybean Isoflavone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Volunteers;
大豆异黄酮对健康人体内华法林药动学和药效学的影响